Sort
40,608 grants matching “prostate cancer”
Mitochondrial Hsp90 chaperones and prostate cancer therapy
$713,736Dario C. Altieri · Wistar Institute · P01 · FY2010 · CA
GENOMEWIDE SEARCH ONCOGENIC PATHWAYS COOPERATING WITH ETS FUSTIONS IN PROSTATE CANCER
$713,645Brigham & Womens Hospital Inc · · FY2011 · Department of the Army
Single Molecule Fiber Arrays for the Detection of Low Abundance Proteins
$713,497David C Duffy · Quanterix Corporation · R44 · FY2013 · CA
NanoCytology to mitigate overdiagnosis of prostate cancer
$713,412Hariharan Subramanian · Nanocytomics, Llc · R44 · FY2016 · CA
Accurate and unbiased single cell sequencing with digital droplet MDA
$713,363Adam R. Abate · University Of California, San Francisco · R01 · FY2016 · HG
ROLE OF MICRORNA IN AGGRESSIVE PROSTATE CANCER
$713,250The University Of Texas Southwestern Medical Center · · FY2011 · Department of Defense
Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors
$712,969Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI
$712,949Daniel B Vigneron · University Of California, San Francisco · R01 · FY2016 · EB
Transgenic Core Facility
$712,923Deborah Swing · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy
$712,866Nagavarakishore Pillarsetty · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
SAN ANTONIO CANCER INSTITUTE
$712,822Cancer Therapy And Research Center · P30 · FY2003 · CA
San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR)
$712,800Ian M Thompson · University Of Texas Hlth Science Center · U01 · FY2010 · CA
TRANSGENIC MOUSE MODELS OF PROSTATE CANCER
$712,780Baylor College Of Medicine · U01 · FY2002 · CA
Interactive Image Guided Closed Loop Thermal Therapy
$712,759Roger J McNichols · Biotex, Inc. · R44 · FY2007 · CA
CANCER PREVENTION AND CONTROL TRAINING GRANT
$712,733University Of Arizona · R25 · FY2001 · CA
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
$712,729Hirak S. Basu · University Of Wisconsin-Madison · R01 · FY2015 · CA
MOUSE MODELS FOR HUMAN PROSTATE CANCER
$712,536University Of California Los Angeles · U01 · FY2001 · CA
Development of Best-in-Class Pol-Theta Inhibitors
$712,514Richard T Pomerantz · Thomas Jefferson University · R01 · FY2024 · CA
OSTEOPOROTIC FRACTURES IN MEN (MR.OS)
$712,297Oregon Health And Science University · U01 · FY2005 · AR
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$712,278Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
The Role of Fgf Signaling in Vertebrate Development
$712,253Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
$712,200Karen J Wernli · Kaiser Foundation Research Institute · R01 · FY2021 · CA
Mechanisms Underlying Replication Stress And Genome Instability Upon BRCA2 Deficiency
$712,077Shailja Pathania · University Of Massachusetts Boston · R01 · FY2025 · CA
Uses of GEM models for Translational Cancer Research
$711,971Lynda Chin · University Of Tx Md Anderson Can Ctr · U01 · FY2013 · CA
Role of FSH in postmenopausal obesity and breast cancer
$711,888Jennifer Wright Bea · University Of Arizona · R01 · FY2024 · CA